Prominent Efficacy of Amantadine against Human Borna Disease Virus Infection In Vitro and In Vivo. Comment on Fink et al. Amantadine Inhibits SARS-CoV-2 In Vitro. <i>Viruses</i> 2021, <i>13</i>, 539.

Bode, Liv; Dietrich, Detlef E; Spannhuth, Carsten W; Ludwig, Hanns

Prominent Efficacy of Amantadine against Human Borna Disease Virus Infection In Vitro and In Vivo. Comment on Fink et al. Amantadine Inhibits SARS-CoV-2 In Vitro. Viruses 2021, 13, 539.

Bode, Liv; Dietrich, Detlef E; Spannhuth, Carsten W; Ludwig, Hanns.

Afiliación

Bode L; Joint Senior Scientists, Freelance Bornavirus Workgroup, 14163 Berlin, Germany.
Dietrich DE; Ameos Clinic Hildesheim Psychotherapy and Psychiatry, 31135 Hildesheim, Germany.
Spannhuth CW; Center for Systems Neuroscience, 30559 Hanover, Germany.
Ludwig H; Department of Mental Health, Hannover Medical School, 30625 Hanover, Germany.

Viruses ; 14(3)2022 02 28.

Article en En | MEDLINE | ID: mdl-35336901

Asunto(s)

Virus de la Enfermedad de Borna; Tratamiento Farmacológico de COVID-19; Amantadina/farmacología; Animales; Antivirales/farmacología; Antivirales/uso terapéutico; Humanos; SARS-CoV-2

Palabras clave

amantadine; antiviral; human Borna disease virus; in vitro; in vivo

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Virus de la Enfermedad de Borna / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials Límite: Animals / Humans Idioma: En Revista: Viruses Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google